SEARCH
Valley child gets first dose of experimental drug that could help prolong his life
ABC15
2021-05-25
Views
2
Description
Share / Embed
Download This Video
Report
Woodrow Miller, a 21-month-old toddler, has now received his first infusion of Adrabetadex, an experimental medication for Niemann-Pick Type C disease.
Show more
Share This Video
facebook
google
twitter
linkedin
email
Video Link
Embed Video
<iframe width="600" height="350" src="https://dailytv.net//embed/x81hhmu" frameborder="0" allowfullscreen></iframe>
Preview Player
Download
Report form
Reason
Your Email address
Submit
RELATED VIDEOS
01:05
Scientists Have Developed an Experimental Drug That Could Make You Live Longer
01:00
Valley boy with rare disease allowed access to experimental drug
05:20
Valley family pleads with FDA for access to experimental drug for fatal children’s disease
01:00
Valley boy with rare disease allowed access to experimental drug
02:42
Valley baby showing great progress with experimental Niemann-Pick Type C disease drug treatments
02:15
Valley nurse gets experimental brain cancer treatment
00:18
Best Seller The LDN Book: How a Little-Known Generic Drug _ Low Dose Naltrexone _ Could
00:25
Ebook The LDN Book: How a Little-Known Generic Drug _ Low Dose Naltrexone _ Could Revolutionize
00:07
[PDF] The LDN Book: How a Little-Known Generic Drug Low Dose Naltrexone Could Revolutionize
00:19
Big Deals The LDN Book: How a Little-Known Generic Drug _ Low Dose Naltrexone _ Could
00:07
PDF The LDN Book: How a Little-Known Generic Drug Low Dose Naltrexone Could Revolutionize
00:05
Read The LDN Book: How a Little-Known Generic Drug — Low Dose Naltrexone — Could Revolutionize
